Corpus Intelligence IC Memo — SMMHC 2026-04-26 13:28 UTC
IC Memo — SMMHC
Investment Committee Memorandum | MO | 348 beds | Grade C | EBITDA uplift $5.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SMMHC

CCN 264005 | ST. FRANCOIS, MO | 348 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

SMMHC is a 348-bed suburban community hospital in ST. FRANCOIS, MO with $68.6M in net patient revenue and a -42.9% operating margin. The hospital serves a payer mix of 0.8% Medicare, 3.2% Medicaid, and 96.0% commercial.

Thesis: Undervalued. Our ML models identify $5.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -42.9% to -35.6% (+736bps).

Net Revenue HCRIS$68.6M
Current EBITDA COMPUTED$-29.4M
Operating Margin COMPUTED-42.9%
Occupancy HCRIS92.0%
Revenue / Bed COMPUTED$197K
Net-to-Gross HCRIS80.1%
Distress Probability ML44.9%

2. Market Context & Competitive Position

138
MO Hospitals
-6.2%
State Median Margin
31
Comparable Hospitals

MO has 138 Medicare-certified hospitals with a median operating margin of -6.2%. The target's margin of -42.9% places it below the state median. Among 31 size-comparable peers (174-696 beds), the median margin is -1.3%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (174-696), prioritizing same-state peers. 31 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SMMHC (Target)MO348$68.6M-42.9%
CHILDRENS MERCY HOSPITALMO328$1.44B30.5%
UNIV OF MISSOURI HEALTH CAREMO521$1.36B-2.0%
MERCY HOSPITAL SPRINGFIELDMO617$1.05B6.1%
ST. LOUIS CHILDRENS HOSPITALMO445$886.1M6.4%
SAINT LUKES HOSPITAL OF KANSASMO466$883.5M-12.4%
SSM HEALTH ST. MARYS HOSPITAL MO501$792.8M-0.0%
SSM SAINT LOUIS UNIVERSITY HOSMO317$772.2M-6.4%
MISSOURI BAPTIST MEDICAL CENTEMO402$716.0M2.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $5.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.4M+210bp18mo
Cost to Collect4.5%2.5%$1.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.4M+198bp12mo
A/R Days Reduction5200.0%3800.0%$835K+122bp9mo
Clean Claim Rate88.0%96.0%$44K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.4M
Cost to Collect
$1.4M
Denial Rate Reduction
$1.4M
A/R Days Reduction
$835K
Clean Claim Rate
$44K
Total EBITDA Uplift$5.0M
Current EBITDA$-29.4M
+ RCM Uplift+$5.0M
Pro Forma EBITDA$-24.4M
Current Margin-42.9%
Pro Forma Margin-35.6%
WC Released (1x)$2.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-45.3M$-143.7M0.00x-100.0%
Base (11x exit)10.0x11.0x$-45.3M$-172.8M0.00x-100.0%
Bull Case9.0x11.0x$-40.8M$-170.8M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-40.8M$-198.4M0.00x-100.0%
Bear Case11.0x10.0x$-49.8M$-154.2M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-49.8M$-185.8M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 31 hospitals with 174-696 beds
  • Same-state prioritization (n=32)
  • Comp margins: P25=-9.2% / P50=-1.3% / P75=5.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.